“After a period of falling Covid-19 illness rates, the recent spread of the delta variant of SARS CoV-2 was a major disappointment and necessitated a reexamination of some previous assumptions. This reconsideration may, at least in part, be a correction to overly optimistic views of what highly effective SARS-CoV-2 vaccines could accomplish. Some observers had hoped the vaccines could eliminate transmission of the virus, the ultimate goal of reaching herd immunity. 1 A more likely picture of our future with this virus comes into focus if we examine the well-known infection patterns of another respiratory virus, influenza, both in and outside pandemics. That experience can help us reset expectations and modify goals for dealing with SARS-CoV-2 as it further adapts to a global spread.
In ICU annex environments, containing airflow means isolating susceptible patients and drastically improving their chances for recovery.”
To read more from Arnold A. Monto, M.D. on the future of SARS-CoV-2 vaccination, please visit You First Services, Inc.
The rise in wildfires globally brings into sharp focus how such disasters increasingly threaten our health and security.
Respiratory virus activity across the United States has climbed to high levels, driven by increases in influenza and respiratory syncytial virus (RSV) activity
Weekly US Influenza Surveillance Report: Key Updates for Week 52, ending December 27, 2025. Key points
Seasonal influenza activity is elevated and continues to increase across the country.